Hedge FundCIK0001055951LocationNEW YORK, NY 10022, United States
Long U.S. equity positions disclosed to the SEC on Form 13F-HR.
Latest filingQ2 2026Quarter ended30 Jun 2026Filed14 Aug 2026
Firm profile · Form ADV
SEC adviser registration
OrbiMed is an investment manager exclusively focused on the healthcare sector, managing approximately $13.6 billion on a discretionary basis for 32 clients as of December 31, 2025. The firm provides discretionary investment management services to U.S. and non-U.S. public and private funds, utilizing strategies that involve evaluating companies within the global healthcare sector, including pharmaceutical, biotechnology, medical device, and healthcare services. These strategies generally include investments in securities of U.S. and non-U.S. public and/or private companies within the healthcare sector, subject to each client's investment program.Summarised from the firm’s Form ADV Part 2A brochure.